A. Jasovich

发表

Endocarditis due to vancomycin-resistant Enterococcus raffinosus successfully treated with linezolid: case report and review of literature.

H. Lopardo, A. Ganaha, A. Jasovich, 2008, Revista Argentina de microbiologia.

Efficacy of Amoxicillin-Sulbactam, Given Twice-a-Day, for the Treatment of Community-Acquired Pneumonia: A Clinical Trial Based on a Pharmacodynamic Model

L. Larrateguy, C. Bantar, D. Curcio, 2002, Journal of chemotherapy.

Rationale for Treating Community-Acquired Lower Respiratory Tract Infections with Amoxicillin/Sulbactam Combination Through Pharmacodynamic Analysis in the Setting of Aminopenicillin-Resistant Organisms

C. Bantar, J. Smayevsky, H. Arenoso, 2001, Journal of chemotherapy.

Integrated results of 2 phase 3 studies comparing tigecycline and levofloxacin in community-acquired pneumonia.

C. Tanaseanu, N. Dartois, G. Dukart, 2008, Diagnostic microbiology and infectious disease.

[Updated acute community-acquired pneumonia in adults: Guidelines for initial antimicrobial therapy based on local evidence from the South American Working Group (ConsenSur II)].

F. Rossi, M. Losanovscky, G. Lopardo, 2010, Revista chilena de infectologia : organo oficial de la Sociedad Chilena de Infectologia.

Acute Community-Acquired Pneumonia in Adults: Guidelines for Initial Antimicrobial Therapy Based on Local Evidence from a South American Working Group (ConsenSur)

L. Bavestrello, C. Bantar, D. Curcio, 2002, Journal of chemotherapy.

Efficacy and tolerability of IV doripenem versus meropenem in adults with complicated intra-abdominal infection: a phase III, prospective, multicenter, randomized, double-blind, noninferiority study.

I. Friedland, K. Kaniga, C. Lucasti, 2008, Clinical therapeutics.

A MULTICENTRE, DOUBLE‐BLIND, RANDOMISED STUDY COMPARING THE EFFICACY AND SAFETY OF ORAL LEVOFLOXACIN VERSUS CIPROFLOXACIN IN THE TREATMENT OF UNCOMPLICATED SKIN AND SKIN STRUCTURE INFECTIONS

W. Neto, J. Robledo, A. Nicodemo, 1998, International journal of clinical practice.

A prospective, multicenter, randomized, double-blind study comparing ertapenem and ceftriaxone followed by appropriate oral therapy for complicated urinary tract infections in adults.

G. Woods, R. Gesser, Q. Jiang, 2002, Urology.

Pharmacokinetics and Pharmacodynamics of Amoxicillin-Sulbactam, a Novel Aminopenicillin–β-Lactamase Inhibitor Combination, against Escherichia coli

M. Galas, A. Rossi, C. Bantar, 1999, Antimicrobial Agents and Chemotherapy.

Safety and efficacy of intravenous tigecycline in treatment of community-acquired pneumonia: results from a double-blind randomized phase 3 comparison study with levofloxacin.

Arthur J. L. Cooper, G. Dukart, R. Mallick, 2009, Diagnostic microbiology and infectious disease.

Comparative clinical evaluation of imipenem/cilastatin vs. cefotaxime in treatment of severe bacterial infections.

D. Stamboulian, F. Maglio, A. Jasovich, 1985, Reviews of infectious diseases.

Kidney transplantation and Chagas' disease. A two-year follow-up of a patient with parasitemia.

R. Favaloro, D. Stamboulian, S. González-cappa, 1983, Transplantation.

Chagas' disease and kidney transplantation--follow-up of nine patients for 11 years.

S. González-cappa, A. Jasovich, D. Gotlieb, 1992, Transplantation proceedings.

P834 Treatment of complicated intra-abdominal infections: doripenem versus meropenem

K. Kaniga, C. Lucasti, A. Jasovich, 2007 .

Amoxicillin-sulbactam: A combination with a sound pharmacokinetic-pharmacodynamic basis.

A. Jasovich, 2001, Drugs of today.

A randomized placebo-controlled phase II study of a Pseudomonas vaccine in ventilated ICU patients

J. Vincent, J. Rello, T. Welte, 2017, Critical Care.

A Pharmacodynamic Model to Support a 12-Hour Dosing Interval for Amoxicillin/Sulbactam, a Novel Oral Combination, in the Treatment of Community-Acquired Lower Respiratory Tract Infections

C. Bantar, J. Smayevsky, H. Arenoso, 2000, Journal of chemotherapy.

Review of Pharmacokinetic, Pharmacodynamic and Clinical Studies with a Modern Combination of Amoxicillin/Sulbactam

J. Casellas, C. Bantar, H. Arenoso, 2006, Chemotherapy.

Acute Community-Acquired Pneumonia in Adults: Guidelines for Initial Antimicrobial Therapy Based on Local Evidence from a South American Working Group (ConsenSur)

H. Sader, L. Bavestrello, J. Labarca, 2002, Journal of chemotherapy.

FOCUS 2: a randomized, double-blinded, multicentre, Phase III trial of the efficacy and safety of ceftaroline fosamil versus ceftriaxone in community-acquired pneumonia.

J. Milanowski, T. File, D. Górecka, 2011, The Journal of antimicrobial chemotherapy.

A randomized placebo-controlled phase II study of a Pseudomonas vaccine in ventilated ICU patients

J. Vincent, J. Rello, T. Welte, 2017 .

Impact of the Infectious Disease Team on the Rationale for Antibiotic Usage: An Expeditious Intervention Strategy Which Avoids Limiting the Physician's Freedom

C. Belloni, D. Curcio, A. Jasovich, 2003, Journal of chemotherapy.